Most Recent
Tokio Marine subsidiary Bond & Credit Company and fired underwriter Greg Brereton have been pulled into lawsuits targeting Insurance Australia Group over trade credit policies covering $4.6 billion in loans issued by the now collapsed Greensill Capital.
Labour hire firm CoreStaff will pay $6.4 million to settle a class action accusing it of using the promise of long-term work to lure workers to Australia from Papua New Guinea, only to terminate their employment agreements less than three years after they made the move.
A Sydney barrister has launched a defamation lawsuit against the Nine Network over its coverage of a battle for custody of famed social media hound Oscar the cavoodle.
Grain producer Viterra, which has been ordered to pay $293 million to Cargill Australia for making misleading representations during the sale of malt producer Joe White, rejected an offer to settle the lawsuit for $85 million, a court has heard.
Administrators for building giant ProBuild have won more time to examine its assets as they try to avoid the "nightmarish prospect" of costly delays to the company's projects.
The WA Supreme Court has thrown out challenges to Woodside Energy's proposals to expand its Scarborough LNG project, finding there were no errors in the state EPA's approval.
Cosmetics company MCoBeauty has reached a settlement with the maker of the popular 1000Hour Lash & Brow Dye kit in a case alleging “deliberate and flagrant” trade mark and copyright infringement.
The financial crimes watchdog has brought enforcement action against Crown Mebourne and Crown Perth for what it describe as widespread and serious non-compliance of anti-money laundering and counter terrorism laws.
The ACCC got what it wanted when IVF providers Virtus Health and Healius terminated a proposed $45 million merger, but it wasn't a win, a judge has said in mostly denying the regulator's bid to recover the costs of its court challenge to the deal.
A judge has found Pfizer's patent for its post-operative injectable painkiller Dynastat is valid and that Australian drug maker Juno Pharmaceuticals infringed the patent by selling generic versions of the drug in Australia.